People

Inhaled insulin developer Aerami Therapeutics (formerly Dance Biopharm) has announced the appointment of Timm Crowder as Chief Operating Officer. Crowder, who was most recently Chief Operating Officer of Spyryx Biosciences, was a co-founder of DPI developer Oriel Therapeutics. Following Oriel's acquisition by Sandoz in 2010, Crowder held a series of manufacturing … [Read more...] about Timm Crowder named Chief Operating Officer of Aerami Therapeutics

Verona Pharma has announced the appointment of former United Therapeutics executive David Zaccardelli as President and CEO, succeeding Jan-Anders Karlsson, who is retiring. Zaccardelli was most recently President and CEO of Dova Pharmaceuticals, which was acquired by Sobi in November 2019. The company also announced the appointment of Mark W. Hahn as Chief Financial … [Read more...] about Verona Pharma appoints David Zaccardelli as President and CEO

Impel NeuroPharma has announced the appointment of Sheena K. Aurora as VP of Medical Affairs, Migraine Franchise. Aurora will handle medical affairs strategy for Impel's INP104 intranasal intranasal dihydroergotamine (DHE) for the treatment of acute migraine. The company announced the initiation of the Phase 3 STOP-301 study of INP104 in August 2018. Aurora was … [Read more...] about Impel NeuroPharma appoints Sheena K. Aurora as VP of Medical Affairs, Migraine Franchise

Finnish "nanoparticle medicine enabling company" Nanoform has announced the appointment of former Catalent executive Sally Langa as Head of US Sales. Langa was most recently VP, Global Business Development, Development and Analytical Services at Catalent Pharma Solutions and has previously held business development/sales positions at Halo Pharmaceutical and Patheon. … [Read more...] about Nanoform names Sally Langa as Head of US Sales

Swedish DPI developer Iconovo has hired former Actelion executive Johan Wäborg as its new CEO, the company said. Wäborg has held a number of positions at Actelion over more than 13 years with the company; he was most recently General Manager for the Nordic countries. According to the company, Wäborg will succeed company founder Orest Lastow sometime before … [Read more...] about Iconovo names Johan Wäborg as new CEO

Adherium has announced the appointment of Jane Lapon as Head of Global Market Access & Reimbursement, where she will be responsible for ensuring reimbursement for the Hailie inhaler monitoring platform. Lapon was most recently VP of Global Market Access at Boston Scientific and has previously held executive positions in global market access roles at BTG (which … [Read more...] about Adherium appoints Jane Lapon as Head of Global Market Access & Reimbursement

CDMO MedPharm has announced the appointment of Lynn Allen as VP of Business Development, responsible for growing the business in North America. Allen has extensive experience in CDMO business development and was most recently Senior Director of Sales and Marketing at Jubilant HollisterStier. She previously held business development positions with Mylan and DPT … [Read more...] about MedPharm appoints Lynn Allen VP of Business Development

OINDP testing experts Copley Scientific have announced the hires of Edward Brundrett, who joins the company as a technical sales executive, and Mark Lo, a mechanical engineer who is joining the company's design team. The company, which significantly expanded its Nottingham, UK headquarters in 2018, noted that its recent acquisition of Novi Systems "brings a new … [Read more...] about Copley Scientific announces hires of sales and design engineers

Inhaler monitoring company Adherium has named Peter Stratford as CEO and Mike Motion as Chief Commercial Officer, replacing interim CEO Jeremy Curnock Cook and interim CCO Bill Hunter. Stratford was most recently Head of Innovation at healthcare company BTG, which has now been acquired by Boston Scientific. Motion was most recently Head of Varithena, a BTG … [Read more...] about Adherium names new CEO, Chief Commercial Officer

Iliad Biotechnology has announced the appointment of Cheryl Keech as Chief Medical Officer and Executive VP of Clinical Research; she will be responsible for clinical studies of the company's pipeline products, including the BPZE1 live attenuated intranasal pertussis vaccine. The company said that a Phase 2b trial of BPZE1 has completed enrollment. Keech was most … [Read more...] about Iliad Biotechnologies appoints Cheryl Keech as Chief Medical Officer and Executive VP of Clinical Research